Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04513782

The Contributions of Age Related Changes in the Sound Localization Pathway to Central Hearing Loss

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
40 Years – 89 Years
Healthy volunteers
Accepted

Summary

Age-related hearing loss, presbycusis, affects up to 50% of American adults. There are two main causes for presbycusis: 1) Progressive death of hair cells in the inner ear, and 2) Central hearing loss, or the reduced ability to decipher the sound source of interest from other competing sounds in a multi-source complex environment. The first cause is better understood and treatment options, such as hearing aids and cochlear implants, are available. However, central hearing loss is not as well understood and there is not a treatment available at this time. This study aims to advance our understanding of central hearing loss by evaluating the abilities of younger and older listeners in two primary outcome measures: to 1) neurologically process sound stimuli and 2) focus on conversational speech in the presence of spatially-separated competing background noise. A test using Auditory Brainstem Responses (ABR) will be used to evaluate the brain's response to clicking sounds. This study will assess all waveform data, but will focus particularly on wave III. Sentence in noise tests will be used to assess each subject's ability to process speech in noisy situations. Both the ABR and sentence in noise tests are non-invasive and are commonly used in audiology practices to diagnosis and treat a variety of audiological pathologies.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAudiological AssessmentsParticipants will all undergo routine audiological assessments. The results from these assessments will be evaluated in order to advance understanding of central hearing loss.

Timeline

Start date
2020-10-01
Primary completion
2026-05-29
Completion
2026-05-29
First posted
2020-08-14
Last updated
2023-08-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04513782. Inclusion in this directory is not an endorsement.